166 related articles for article (PubMed ID: 32496541)
1. Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Röllig C; Kramer M; Schliemann C; Mikesch JH; Steffen B; Krämer A; Noppeney R; Schäfer-Eckart K; Krause SW; Hänel M; Herbst R; Kunzmann V; Einsele H; Jost E; Brümmendorf TH; Scholl S; Hochhaus A; Neubauer A; Sohlbach K; Fransecky L; Kaufmann M; Niemann D; Schaich M; Frickhofen N; Kiani A; Heits F; Krümpelmann U; Kaiser U; Kullmer J; Wass M; Stölzel F; von Bonin M; Middeke JM; Thiede C; Schetelig J; Berdel WE; Ehninger G; Baldus CD; Müller-Tidow C; Platzbecker U; Serve H; Bornhäuser M
Blood; 2020 Aug; 136(7):823-830. PubMed ID: 32496541
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and meta-analysis: Prognostic impact of time from diagnosis to treatment in patients with acute myeloid leukemia.
Franco S; Geng X; Korostyshevskiy V; Karp JE; Lai C
Cancer; 2023 Oct; 129(19):2975-2985. PubMed ID: 37254580
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and survival outcomes of acute myeloid leukemia patients in Taiwan: A national population-based analysis from 2001 to 2015.
Chien LN; Tzeng HE; Liu HY; Chou WC; Tien HF; Hou HA
J Formos Med Assoc; 2023 Jun; 122(6):505-513. PubMed ID: 36369106
[TBL] [Abstract][Full Text] [Related]
4. Effects of Distance From Academic Cancer Center on Overall Survival of Acute Myeloid Leukemia: Retrospective Analysis of Treated Patients.
Dhakal P; Lyden E; Muir KE; Al-Kadhimi ZS; Maness LJ; Gundabolu K; Bhatt VR
Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):e685-e690. PubMed ID: 32660903
[TBL] [Abstract][Full Text] [Related]
5. Time from diagnosis to treatment is associated with survival in patients with acute myeloid leukaemia: An analysis of 55 985 patients from the National Cancer Database.
Alsouqi A; Rothenberger SD; Boyiadzis M; Lontos K
Br J Haematol; 2022 Oct; 199(2):256-259. PubMed ID: 35899627
[TBL] [Abstract][Full Text] [Related]
6. One-Year Survival and Prognosticators of Adults With Acute Leukemia at the Uganda Cancer Institute.
Natukunda B; Omoding A; Bongomin F; Mubiru KR; Ddungu H; Sekaggya-Wiltshire C; Mayanja-Kizza H
JCO Glob Oncol; 2023 Jul; 9():e2200244. PubMed ID: 37499182
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia: Current understanding and management.
Becker M; Farina KA; Mascarenhas J
JAAPA; 2024 Jan; 37(1):34-39. PubMed ID: 38128137
[TBL] [Abstract][Full Text] [Related]
8. Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.
Baden D; Zukunft S; Hernandez G; Wolgast N; Steinhauser S; Pohlmann A; Schliemann C; Mikesch JH; Steffen B; Sauer T; Hanoun M; Schafer-Eckart K; Krause SW; Hanel M; Einsele H; Jost E; Brummendorf TH; Scholl S; Hochhaus A; Neubauer A; Burchert A; Kaufmann M; Niemann D; Schaich M; Blau W; Kiani A; Gorner M; Kaiser U; Kullmer J; Weber T; Berdel WE; Ehninger G; Muller-Tidow C; Platzbecker U; Serve H; Bornhauser M; Rollig C; Baldus CD; Fransecky L
Haematologica; 2024 Apr; ():. PubMed ID: 38654660
[TBL] [Abstract][Full Text] [Related]
9. Trajectories of physical well-being among adults with acute myeloid leukemia.
Jensen-Battaglia M; Sohn MB; Consagra W; Wang Y; Zhang Z; LoCastro M; Davis J; Buettner K; Mortaz S; El-Jawahri AR; Loh KP
Blood Adv; 2024 Jun; 8(11):2612-2621. PubMed ID: 38429079
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Heuser M; Ofran Y; Boissel N; Brunet Mauri S; Craddock C; Janssen J; Wierzbowska A; Buske C;
Ann Oncol; 2020 Jun; 31(6):697-712. PubMed ID: 32171751
[No Abstract] [Full Text] [Related]
11. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.
DiNardo CD; Jonas BA; Pullarkat V; Thirman MJ; Garcia JS; Wei AH; Konopleva M; Döhner H; Letai A; Fenaux P; Koller E; Havelange V; Leber B; Esteve J; Wang J; Pejsa V; Hájek R; Porkka K; Illés Á; Lavie D; Lemoli RM; Yamamoto K; Yoon SS; Jang JH; Yeh SP; Turgut M; Hong WJ; Zhou Y; Potluri J; Pratz KW
N Engl J Med; 2020 Aug; 383(7):617-629. PubMed ID: 32786187
[TBL] [Abstract][Full Text] [Related]
12. How I treat relapsed or refractory AML.
DeWolf S; Tallman MS
Blood; 2020 Aug; 136(9):1023-1032. PubMed ID: 32518943
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.
Lee LYW; Cazier JB; Starkey T; Briggs SEW; Arnold R; Bisht V; Booth S; Campton NA; Cheng VWT; Collins G; Curley HM; Earwaker P; Fittall MW; Gennatas S; Goel A; Hartley S; Hughes DJ; Kerr D; Lee AJX; Lee RJ; Lee SM; Mckenzie H; Middleton CP; Murugaesu N; Newsom-Davis T; Olsson-Brown AC; Palles C; Powles T; Protheroe EA; Purshouse K; Sharma-Oates A; Sivakumar S; Smith AJ; Topping O; Turnbull CD; Várnai C; Briggs ADM; Middleton G; Kerr R;
Lancet Oncol; 2020 Oct; 21(10):1309-1316. PubMed ID: 32853557
[TBL] [Abstract][Full Text] [Related]
14. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.
DiNardo CD; Maiti A; Rausch CR; Pemmaraju N; Naqvi K; Daver NG; Kadia TM; Borthakur G; Ohanian M; Alvarado Y; Issa GC; Montalban-Bravo G; Short NJ; Yilmaz M; Bose P; Jabbour EJ; Takahashi K; Burger JA; Garcia-Manero G; Jain N; Kornblau SM; Thompson PA; Estrov Z; Masarova L; Sasaki K; Verstovsek S; Ferrajoli A; Weirda WG; Wang SA; Konoplev S; Chen Z; Pierce SA; Ning J; Qiao W; Ravandi F; Andreeff M; Welch JS; Kantarjian HM; Konopleva MY
Lancet Haematol; 2020 Oct; 7(10):e724-e736. PubMed ID: 32896301
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse.
Onecha E; Rapado I; Luz Morales M; Carreño-Tarragona G; Martinez-Sanchez P; Gutierrez X; Sáchez Pina JM; Linares M; Gallardo M; Martinez-López J; Ayala R
Haematologica; 2021 Sep; 106(9):2325-2333. PubMed ID: 32732356
[TBL] [Abstract][Full Text] [Related]
16. Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial.
Burd A; Levine RL; Ruppert AS; Mims AS; Borate U; Stein EM; Patel P; Baer MR; Stock W; Deininger M; Blum W; Schiller G; Olin R; Litzow M; Foran J; Lin TL; Ball B; Boyiadzis M; Traer E; Odenike O; Arellano M; Walker A; Duong VH; Kovacsovics T; Collins R; Shoben AB; Heerema NA; Foster MC; Vergilio JA; Brennan T; Vietz C; Severson E; Miller M; Rosenberg L; Marcus S; Yocum A; Chen T; Stefanos M; Druker B; Byrd JC
Nat Med; 2020 Dec; 26(12):1852-1858. PubMed ID: 33106665
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With
Burchert A; Bug G; Fritz LV; Finke J; Stelljes M; Röllig C; Wollmer E; Wäsch R; Bornhäuser M; Berg T; Lang F; Ehninger G; Serve H; Zeiser R; Wagner EM; Kröger N; Wolschke C; Schleuning M; Götze KS; Schmid C; Crysandt M; Eßeling E; Wolf D; Wang Y; Böhm A; Thiede C; Haferlach T; Michel C; Bethge W; Wündisch T; Brandts C; Harnisch S; Wittenberg M; Hoeffkes HG; Rospleszcz S; Burchardt A; Neubauer A; Brugger M; Strauch K; Schade-Brittinger C; Metzelder SK
J Clin Oncol; 2020 Sep; 38(26):2993-3002. PubMed ID: 32673171
[TBL] [Abstract][Full Text] [Related]
18. Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.
Wei AH; Döhner H; Pocock C; Montesinos P; Afanasyev B; Dombret H; Ravandi F; Sayar H; Jang JH; Porkka K; Selleslag D; Sandhu I; Turgut M; Giai V; Ofran Y; Kizil Çakar M; Botelho de Sousa A; Rybka J; Frairia C; Borin L; Beltrami G; Čermák J; Ossenkoppele GJ; La Torre I; Skikne B; Kumar K; Dong Q; Beach CL; Roboz GJ;
N Engl J Med; 2020 Dec; 383(26):2526-2537. PubMed ID: 33369355
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cells.
Raffel S; Klimmeck D; Falcone M; Demir A; Pouya A; Zeisberger P; Lutz C; Tinelli M; Bischel O; Bullinger L; Thiede C; Flörcken A; Westermann J; Ehninger G; Ho AD; Müller-Tidow C; Gu Z; Herrmann C; Krijgsveld J; Trumpp A; Hansson J
Blood; 2020 Sep; 136(13):1507-1519. PubMed ID: 32556243
[TBL] [Abstract][Full Text] [Related]
20. NPM1-mutated acute myeloid leukemia: from bench to bedside.
Falini B; Brunetti L; Sportoletti P; Martelli MP
Blood; 2020 Oct; 136(15):1707-1721. PubMed ID: 32609823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
